Successful treatment with amoxicillin-clavulanic acid: cutaneous nocardiosis caused by Nocardia brasiliensis

J Dermatolog Treat. 2023 Dec;34(1):2229467. doi: 10.1080/09546634.2023.2229467.

Abstract

Aim: To emphasize the role of non-sulfonamides in the treatment of Nocardia infection and reduce the adverse reactions caused by sulfonamides.

Methods: We retrospectively analyzed a case of cutaneous nocardiosis in an immunocompetent individual. The colonies obtained by staining the pus in the lesion with antacid and culturing the agar plates were identified by flight mass spectrometry. The pathogenic identification showed Nocardia brasiliensis infection and the patient was treated with amoxicillin-clavulanic acid.

Results: After treatment with amoxicillin and clavulanic acid, the ulcer gradually peeled and crusted, leaving dark pigmentation. The patient has finally recovered.

Conclusion: Sulfonamides are the first-line antibacterial agents for years in treatment of nocardiosis but are of great toxicity and side effects. This patient was successfully treated with amoxicillin-clavulanic acid and it provided a reference protocol for patients with sulfonamide-resistant Nocardia or sulfonamides intolerance.

Keywords: Nocardia brasiliensis; Sulfonamides; amoxicillin-clavulanic acid; nocardiosis; toxic side effects.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Amoxicillin-Potassium Clavulanate Combination* / therapeutic use
  • Anti-Bacterial Agents* / therapeutic use
  • Female
  • Humans
  • Nocardia
  • Nocardia Infections* / drug therapy
  • Skin Diseases, Bacterial* / drug therapy
  • Treatment Outcome

Substances

  • Amoxicillin-Potassium Clavulanate Combination
  • Anti-Bacterial Agents

Supplementary concepts

  • Nocardia brasiliensis